{"id":"W4405049075","doi":"10.1182/blood-2024-210199","title":"A Canadian Cost-Utility Analysis of Epcoritamab Versus Current Therapies in Third-Line or Later Large B-Cell Lymphoma","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Lenalidomide; Rituximab; Population; Chemoimmunotherapy; Internal medicine; Oncology; Lymphoma; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004758976,0.001342056,0.001384157,0.00247535,0.0008316502,0.002099632,0.002222763,0.000921744,0.004800199],"category_scores_gemma":[0.01007656,0.0006891845,0.003390243,0.003838381,0.000777712,0.000605488,0.001145115,0.001666287,0.0002329996],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07086482,"about_ca_system_score_gemma":0.03358557,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9457436,"about_ca_topic_score_gemma":0.901328,"domain_scores_codex":[0.9980612,0.0008550577,0.00005991134,0.0002261035,0.0003510418,0.0004466558],"domain_scores_gemma":[0.9956784,0.002241938,0.0004826557,0.0001567874,0.0009408951,0.0004993726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.007668533,0.0005076192,0.06762589,0.001110682,0.004453077,0.0005389904,0.0001952802,0.8563001,0.0005533538,0.01659617,0.01624962,0.0282007],"study_design_scores_gemma":[0.002065155,0.001358636,0.08007591,0.0003860597,0.004049179,0.0003375188,0.0005003661,0.8920447,0.0003149197,0.003301928,0.01535715,0.0002085152],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9097944,0.0123673,0.007589981,0.003717863,0.0001368861,0.001268829,0.04061408,0.000196518,0.02431405],"genre_scores_gemma":[0.985084,0.001672795,0.002601157,0.0002909103,0.00002555467,0.0001915581,0.007778047,0.00003454225,0.002321373],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9291352,"threshold_uncertainty_score":0.5141627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04157747449611753,"score_gpt":0.3403610146190639,"score_spread":0.2987835401229464,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}